These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 15704213

  • 1. Enalapril and hydroxyurea therapy for children with sickle nephropathy.
    Fitzhugh CD, Wigfall DR, Ware RE.
    Pediatr Blood Cancer; 2005 Dec; 45(7):982-5. PubMed ID: 15704213
    [Abstract] [Full Text] [Related]

  • 2. Enalapril reduces the albuminuria of patients with sickle cell disease.
    Aoki RY, Saad ST.
    Am J Med; 1995 May; 98(5):432-5. PubMed ID: 7733120
    [Abstract] [Full Text] [Related]

  • 3. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
    Suzuki H, Kanno Y, Nakamoto H, Okada H, Sugahara S.
    Clin Exp Hypertens; 2005 May; 27(2-3):129-38. PubMed ID: 15835375
    [Abstract] [Full Text] [Related]

  • 4. Short-term follow-up of patients with sickle cell disease and albuminuria.
    Alvarez O, Lopez-Mitnik G, Zilleruelo G.
    Pediatr Blood Cancer; 2008 Jun; 50(6):1236-9. PubMed ID: 18293385
    [Abstract] [Full Text] [Related]

  • 5. Hydroxyurea therapy associated with declining serum levels of magnesium in children with sickle cell anemia.
    Altura RA, Wang WC, Wynn L, Altura BM, Altura BT.
    J Pediatr; 2002 May; 140(5):565-9. PubMed ID: 12032523
    [Abstract] [Full Text] [Related]

  • 6. Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme.
    Falk RJ, Scheinman J, Phillips G, Orringer E, Johnson A, Jennette JC.
    N Engl J Med; 1992 Apr 02; 326(14):910-5. PubMed ID: 1542341
    [Abstract] [Full Text] [Related]

  • 7. Protective role of hemoglobin and fetal hemoglobin in early kidney disease for children with sickle cell anemia.
    Lebensburger J, Johnson SM, Askenazi DJ, Rozario NL, Howard TH, Hilliard LM.
    Am J Hematol; 2011 May 02; 86(5):430-2. PubMed ID: 21523807
    [Abstract] [Full Text] [Related]

  • 8. Proteinuria in children with sickle cell disease.
    Marsenic O, Couloures KG, Wiley JM.
    Nephrol Dial Transplant; 2008 Feb 02; 23(2):715-20. PubMed ID: 18065783
    [Abstract] [Full Text] [Related]

  • 9. Prevalence, prevention, and treatment of microalbuminuria and proteinuria in children with sickle cell disease.
    McKie KT, Hanevold CD, Hernandez C, Waller JL, Ortiz L, McKie KM.
    J Pediatr Hematol Oncol; 2007 Mar 02; 29(3):140-4. PubMed ID: 17356390
    [Abstract] [Full Text] [Related]

  • 10. Long-term results using hydroxyurea/phlebotomy for reducing secondary stroke risk in children with sickle cell anemia and iron overload.
    Greenway A, Ware RE, Thornburg CD.
    Am J Hematol; 2011 Apr 02; 86(4):357-61. PubMed ID: 21442640
    [Abstract] [Full Text] [Related]

  • 11. Prevention of secondary stroke and resolution of transfusional iron overload in children with sickle cell anemia using hydroxyurea and phlebotomy.
    Ware RE, Zimmerman SA, Sylvestre PB, Mortier NA, Davis JS, Treem WR, Schultz WH.
    J Pediatr; 2004 Sep 02; 145(3):346-52. PubMed ID: 15343189
    [Abstract] [Full Text] [Related]

  • 12. Hydroxyurea treatment decreases glomerular hyperfiltration in children with sickle cell anemia.
    Aygun B, Mortier NA, Smeltzer MP, Shulkin BL, Hankins JS, Ware RE.
    Am J Hematol; 2013 Feb 02; 88(2):116-9. PubMed ID: 23255310
    [Abstract] [Full Text] [Related]

  • 13. Hydroxyurea treatment in children with sickle cell anemia in Central America and the Caribbean countries.
    Svarch E, Machín S, Nieves RM, Mancia de Reyes AG, Navarrete M, Rodríguez H.
    Pediatr Blood Cancer; 2006 Jul 02; 47(1):111-2. PubMed ID: 16550531
    [No Abstract] [Full Text] [Related]

  • 14. Hydroxyurea therapy: improving the lives of patients with sickle cell disease.
    Anderson N.
    Pediatr Nurs; 2006 Jul 02; 32(6):541-3. PubMed ID: 17256291
    [Abstract] [Full Text] [Related]

  • 15. Glomerular involvement in adults with sickle cell hemoglobinopathies: Prevalence and clinical correlates of progressive renal failure.
    Guasch A, Navarrete J, Nass K, Zayas CF.
    J Am Soc Nephrol; 2006 Aug 02; 17(8):2228-35. PubMed ID: 16837635
    [Abstract] [Full Text] [Related]

  • 16. A two-year pilot trial of hydroxyurea in very young children with sickle-cell anemia.
    Wang WC, Wynn LW, Rogers ZR, Scott JP, Lane PA, Ware RE.
    J Pediatr; 2001 Dec 02; 139(6):790-6. PubMed ID: 11743503
    [Abstract] [Full Text] [Related]

  • 17. Effects of hydroxyurea in a population of Brazilian patients with sickle cell anemia.
    Vicari P, Barretto de Mello A, Figueiredo MS.
    Am J Hematol; 2005 Mar 02; 78(3):243-4. PubMed ID: 15726590
    [Abstract] [Full Text] [Related]

  • 18. UGT1A promoter polymorphisms influence bilirubin response to hydroxyurea therapy in sickle cell anemia.
    Heeney MM, Howard TA, Zimmerman SA, Ware RE.
    J Lab Clin Med; 2003 Apr 02; 141(4):279-82. PubMed ID: 12677174
    [Abstract] [Full Text] [Related]

  • 19. Changes in urine albumin to creatinine ratio with the initiation of hydroxyurea therapy among children and adolescents with sickle cell disease.
    Tehseen S, Joiner CH, Lane PA, Yee ME.
    Pediatr Blood Cancer; 2017 Dec 02; 64(12):. PubMed ID: 28612449
    [Abstract] [Full Text] [Related]

  • 20. Albuminuria and renal function in homozygous sickle cell disease: observations from a cohort study.
    Thompson J, Reid M, Hambleton I, Serjeant GR.
    Arch Intern Med; 2007 Apr 09; 167(7):701-8. PubMed ID: 17420429
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.